-
公开(公告)号:US20240140978A1
公开(公告)日:2024-05-02
申请号:US18345407
申请日:2023-06-30
申请人: Caris Science, Inc.
发明人: Heather O`Neill , Günter Mayer , Mark Miglarese , David Spetzler
IPC分类号: C07H19/173 , A61K9/00 , A61K47/69 , A61P9/00 , A61P25/28 , A61P29/00 , A61P31/00 , A61P35/02 , A61P37/00 , C07H19/09 , C07H19/19 , C07H21/00 , C12N15/10 , C12N15/115 , C12Q1/6886 , G01N33/53 , G01N33/574 , G01N33/68 , G06T7/00
CPC分类号: C07H19/173 , A61K9/0014 , A61K9/0019 , A61K9/0053 , A61K47/6911 , A61K47/6929 , A61P9/00 , A61P25/28 , A61P29/00 , A61P31/00 , A61P35/02 , A61P37/00 , C07H19/09 , C07H19/19 , C07H21/00 , C12N15/10 , C12N15/115 , C12Q1/6886 , G01N33/5308 , G01N33/57484 , G01N33/68 , G06T7/0012 , C12N2310/16 , C12N2320/10 , C12Q2600/158
摘要: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.
-
公开(公告)号:US20200376022A1
公开(公告)日:2020-12-03
申请号:US16497024
申请日:2018-03-27
申请人: Caris Science, Inc.
发明人: Valeriy Domenyuk , Xianghua Liu , Mark Miglarese , David Spetzler
IPC分类号: A61K31/7125 , C12Q1/6811 , C12Q1/6886
摘要: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include circulating biomarkers such as micro vesicles, including those derived from various diseases.
-
公开(公告)号:US10731166B2
公开(公告)日:2020-08-04
申请号:US16084504
申请日:2017-03-18
申请人: Caris Science, Inc.
IPC分类号: C12N15/115 , C12N15/10 , C12Q1/6883 , C12Q1/6886
摘要: Methods and compositions are provided to identify oligonucleotides that bind targets of interest. The targets include tissues, cells, circulating biomarkers such as microvesicles, including those derived from various diseases. The oligonucleotides can be used in diagnostic and therapeutic applications.
-
公开(公告)号:US20200032265A1
公开(公告)日:2020-01-30
申请号:US16337367
申请日:2017-09-27
申请人: CARIS SCIENCE, INC.
IPC分类号: C12N15/115 , C12Q1/70 , A61K31/7088
摘要: Methods and compositions are provided for oligonucleotides and libraries of oligonucleotides that bind targets of interest. The targets include cellular biomarkers of viral infection. The viral infection may be that of human immunodeficiency virus-1.
-
公开(公告)号:US20240247273A1
公开(公告)日:2024-07-25
申请号:US18531328
申请日:2023-12-06
申请人: Caris Science, Inc.
发明人: Heather O'Neill , Mark Miglarese , David Spetzler
IPC分类号: C12N15/115 , A61K31/711 , A61K47/68 , G01N33/53
CPC分类号: C12N15/115 , A61K31/711 , A61K47/6807 , G01N33/53 , C12N2310/16 , C12N2310/3513 , C12N2320/10 , G01N2333/4716 , G01N2333/70503 , Y02A50/30
摘要: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a therapeutic target such as Complement Component 1, Q Subcomponent (C1q) or a subunit thereof.
-
公开(公告)号:US11725023B2
公开(公告)日:2023-08-15
申请号:US17166071
申请日:2021-02-03
申请人: Caris Science, Inc.
发明人: Heather O'Neill , Günter Mayer , Mark Miglarese , David Spetzler
IPC分类号: C12N15/115 , C07H19/173 , A61K47/69 , A61P37/00 , A61P25/28 , A61P31/00 , A61P9/00 , A61P35/02 , A61P29/00 , A61K9/00 , C07H19/09 , C07H19/19 , C07H21/00 , C12N15/10 , C12Q1/6886 , G06T7/00 , G01N33/574 , G01N33/53 , G01N33/68
CPC分类号: C07H19/173 , A61K9/0014 , A61K9/0019 , A61K9/0053 , A61K47/6911 , A61K47/6929 , A61P9/00 , A61P25/28 , A61P29/00 , A61P31/00 , A61P35/02 , A61P37/00 , C07H19/09 , C07H19/19 , C07H21/00 , C12N15/10 , C12N15/115 , C12Q1/6886 , G01N33/5308 , G01N33/57484 , G01N33/68 , G06T7/0012 , C12N2310/16 , C12N2320/10 , C12Q2600/158
摘要: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.
-
公开(公告)号:US10941176B2
公开(公告)日:2021-03-09
申请号:US15745407
申请日:2016-07-28
申请人: Caris Science, Inc.
发明人: Heather O'Neill , Günter Mayer , Mark Miglarese , David Spetzler
IPC分类号: C12N15/11 , C07H19/173 , A61K47/69 , A61P37/00 , A61P25/28 , A61P31/00 , A61P9/00 , A61P35/02 , A61P29/00 , A61K9/00 , C07H19/09 , C07H19/19 , C07H21/00 , C12N15/10 , C12N15/115 , C12Q1/6886 , G06T7/00 , G01N33/574 , G01N33/53 , G01N33/68
摘要: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.
-
公开(公告)号:US20210062191A1
公开(公告)日:2021-03-04
申请号:US16897976
申请日:2020-06-10
申请人: Caris Science, Inc.
IPC分类号: C12N15/115 , C12N15/10 , C12Q1/6883 , C12Q1/6886
摘要: Methods and compositions are provided to identify oligonucleotides that bind targets of interest. The targets include tissues, cells, circulating biomarkers such as microvesicles, including those derived from various diseases. The oligonucleotides can be used in diagnostic and therapeutic applications.
-
公开(公告)号:US11332748B2
公开(公告)日:2022-05-17
申请号:US16897976
申请日:2020-06-10
申请人: Caris Science, Inc.
IPC分类号: C12N15/115 , C12N15/10 , C12Q1/6883 , C12Q1/6886
摘要: Methods and compositions are provided to identify oligonucleotides that bind targets of interest. The targets include tissues, cells, circulating biomarkers such as microvesicles, including those derived from various diseases. The oligonucleotides can be used in diagnostic and therapeutic applications.
-
公开(公告)号:US20220073919A1
公开(公告)日:2022-03-10
申请号:US17377046
申请日:2021-07-15
申请人: Caris Science, Inc.
发明人: Heather O'Neill , Mark Miglarese , David Spetzler
IPC分类号: C12N15/115 , A61K31/711 , A61K47/68 , G01N33/53
摘要: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a therapeutic target such as Complement Component 1, Q Subcomponent (C1q) or a subunit thereof.
-
-
-
-
-
-
-
-
-